SCHEMBL21031986

SCHEMBL21031986

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3c2sc2ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 5/20 0.51
▸ DUSP3 P51452 2/20 0.44
▸ PTPRC P08575 1/20 0.44
▸ PTPRF P10586 1/20 0.44
▸ PTPRA P18433 1/20 0.44
▸ PTPRB P23467 1/20 0.44
▸ PTPN6 P29350 1/20 0.44
▸ PTPN12 Q05209 1/20 0.44
▸ GPR3 P46089 1/20 0.43
▸ TNKS O95271 2/20 0.41
▸ TNKS2 Q9H2K2 2/20 0.41
▸ MAP3K9 P80192 3/20 0.41
▸ MAP3K11 Q16584 3/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24238397 0.89 PTPN1 (0.44) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL24510849 0.89 TNKS (0.45) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL12425640 0.87 TNKS (0.44) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL23168848 0.86 PTPN1 (0.40) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL24238475 0.84 PTPN1 (0.43) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL24238493 0.84 PTPN1 (0.43) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL14882965 0.84 PTPN1 (0.44) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL12425520 0.84 L3MBTL1 (0.43) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL24238472 0.83 PTPN1 (0.42) PTPN1DUSP3PTPRCPTPRFPTPRA
SCHEMBL15784162 0.82 PTPN1 (0.41) PTPN1DUSP3PTPRCPTPRFPTPRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 PTPN1 4737/4885DUSP3 4727/4885PTPRC 4337/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 PTPN1 4737/4885DUSP3 4727/4885PTPRC 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback